EAU-EANM-ESTRO-ESUR-SIOG guidelines on prostate cancer—2020 update. Part 1: screening, diagnosis, and local treatment with curative intent
N Mottet, RCN van den Bergh, E Briers… - European urology, 2021 - Elsevier
Objective To present a summary of the 2020 version of the European Association of Urology
(EAU)-European Association of Nuclear Medicine (EANM)-European Society for …
(EAU)-European Association of Nuclear Medicine (EANM)-European Society for …
Prostate Cancer Biomarkers: From diagnosis to prognosis and precision-guided therapeutics
M Adamaki, V Zoumpourlis - Pharmacology & therapeutics, 2021 - Elsevier
Prostate cancer (PCa) is one of the most commonly diagnosed malignancies and among the
leading causes of cancer-related death worldwide. It is a highly heterogeneous disease …
leading causes of cancer-related death worldwide. It is a highly heterogeneous disease …
Complexities of prostate cancer
Prostate cancer has a long disease history and a wide variety and uncertainty in individual
patients' clinical progress. In recent years, we have seen a revolutionary advance in both …
patients' clinical progress. In recent years, we have seen a revolutionary advance in both …
Cancer-associated fibroblast: role in prostate cancer progression to metastatic disease and therapeutic resistance
Prostate cancer (PCa) is one of the most common cancers in European males. Although
therapeutic approaches have changed in recent years, and several new drugs have been …
therapeutic approaches have changed in recent years, and several new drugs have been …
2015 年中国前列腺癌发病与死亡分析.
付振涛, 郭晓雷, 张思维, 郑荣寿… - Chinese Journal of …, 2020 - search.ebscohost.com
目的分析2015 年中国前列腺癌的发病与死亡情况, 为前列腺癌的防控提供依据.
方法对国家癌症中心收集的全国501 个肿瘤登记处上报的2015 年数据进行质量审核和评估 …
方法对国家癌症中心收集的全国501 个肿瘤登记处上报的2015 年数据进行质量审核和评估 …
Epidemiology of prostate cancer in Europe: patterns, trends and determinants
F Bray, LA Kiemeney - Management of prostate cancer: a multidisciplinary …, 2017 - Springer
Prostate cancer is a substantial public health problem worldwide. It is the most common
neoplasm among men and third-ranked cause of cancer death in Europe, with almost …
neoplasm among men and third-ranked cause of cancer death in Europe, with almost …
Association between obesity and frequency of high‑grade prostate cancer on biopsy in men: A single‑center retrospective study
R Baio, G Napodano, C Caruana… - Molecular and …, 2022 - spandidos-publications.com
The present study aimed to investigate the relationship between BMI and the prostate
cancer (PCa) risk at biopsy in Italian men. Retrospective analyses of the clinical data of …
cancer (PCa) risk at biopsy in Italian men. Retrospective analyses of the clinical data of …
Hereditary prostate cancer–Primetime for genetic testing?
I Heidegger, I Tsaur, H Borgmann, C Surcel… - Cancer treatment …, 2019 - Elsevier
Prostate cancer (PCa) remains the most common cancer in men. The proportion of all PCa
attributable to high-risk hereditary factors has been estimated to 5–15%. Recent landmark …
attributable to high-risk hereditary factors has been estimated to 5–15%. Recent landmark …
[HTML][HTML] Mitochondrial genome variation and prostate cancer: a review of the mutational landscape and application to clinical management
Prostate cancer is a genetic disease. While next generation sequencing has allowed for the
emergence of molecular taxonomy, classification is restricted to the nuclear genome …
emergence of molecular taxonomy, classification is restricted to the nuclear genome …
Dysregulated transcriptional control in prostate cancer
SJ Baumgart, E Nevedomskaya… - International Journal of …, 2019 - mdpi.com
Recent advances in whole-genome and transcriptome sequencing of prostate cancer at
different stages indicate that a large number of mutations found in tumors are present in non …
different stages indicate that a large number of mutations found in tumors are present in non …